the latest yield payout is 6.2%, and there are about 300 drugs on clinical testing in their pipeline, based on March research report,and most of the drugs on trial have the potential to be the first and the best in this industry. The reason I know it because my firm is an US based international investment brokerage, , and follow up blue chip companies' performance everyday, if there is any news or change coming out, I know it at the first time. Hope it helps.